Moderna Inc (MRNA)
Operating return on assets (Operating ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -4,239,000 | 9,420,000 | 13,296,000 | -763,000 | -546,000 |
| Total assets | US$ in thousands | 18,426,000 | 25,858,000 | 24,669,000 | 7,337,000 | 1,589,420 |
| Operating ROA | -23.01% | 36.43% | 53.90% | -10.40% | -34.35% |
December 31, 2023 calculation
Operating ROA = Operating income ÷ Total assets
= $-4,239,000K ÷ $18,426,000K
= -23.01%
Operating ROA is a key profitability ratio that indicates the company's ability to generate operating income from its assets. Moderna Inc's operating ROA has fluctuated significantly over the past five years. In 2023, the operating ROA declined sharply to -23.01%, indicating that the company's operating income generated from its assets decreased significantly compared to the previous year.
In 2022, Moderna Inc achieved a high operating ROA of 36.43%, reflecting a strong performance in generating operating income relative to its assets. The company's operating ROA remained robust in 2021 at 53.90%, indicating efficient utilization of assets to generate operating profits.
However, in 2020, the operating ROA turned negative at -10.40%, suggesting that the company experienced challenges in generating operating income from its assets during that period.
The lowest operating ROA was recorded in 2019 at -34.33%, indicating a significant decline in the company's ability to generate operating income from its assets, potentially due to operational inefficiencies or economic challenges during that year.
Overall, Moderna Inc's operating ROA has been volatile, with both high and low points over the past five years, highlighting the importance of closely monitoring asset utilization and operating income generation for sustainable profitability.
Peer comparison
Dec 31, 2023